Rola osrodkowych receptorow delta-opioidergicznych w aktywnosci mioelektrycznej zoladka owcy

• Autorzy: Kania B F , Wielgosz M.

Warianty tytułu

EN

Role of central delta-opioid receptors in the wall of gastric myoelectrical spike burst activity in sheep

• Języki publikacji: PL

Abstrakty

EN

The present study examined the participation of central δ-opioidergic receptors in the modulatory/ inhibitory effect of [D-Pen²-D-Pen⁵-enkephalin] (DPDPE), a highly selective delta-opioid receptor agonist, on the spike burst activity of the rumen, reticulum and antrum prior to and 10 min after the i.c.v. - during 1 min - infusion of naltrindole, a competitive ä-opioid receptor antagonist in conscious sheep. DPDPE was infused i.c.v. at the doses of 0.25, 0.5 and 1.0 mg × kg⁻¹ B.W., whereas naltrindole - at doses 10 times higher. All the doses of DPDPE infused i.c.v. significantly inhibited myoelectrical activity of the wall of the rumen and reticulum. The effects of DPDPE were prevented by naltrindole previously infused at the doses of 2.5, 5.0 and 10.0 mg × kg⁻¹ B.W. (i.e. at doses 10 times higher than those of DPDPE). The results obtained indicate that central δ-opioid receptors participated in the inhibitory action of specific opioid peptide (DPDPE) on myoelectrical activity of the forestomachs in sheep. Furthermore, these results suggest that it is a specific delta-receptor stimulation, because naltrindole, a compeptitive δ-receptor antagonist, prevented the modulatory/inhibitory action of DPDPE on the reticular and ruminal motility in sheep.

Słowa kluczowe

PL

fizjologia zwierzat; owce; zoladek; aktywnosc mioelektryczna; przewod pokarmowy; aktywnosc motoryczna; receptory delta-opioidoergiczne; agonisci receptorow delta-opioidoergicznych; DPDPE; D-Pen2,D-Pen5-enkefalina zob.DPDPE; naltrindol

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2009
• Tom: 65
• Numer: 05
• Opis fizyczny: s.344-348,rys.,bibliogr.

Twórcy

autor

Kania B F

• Szkola Glowna Gospodarstwa Wiejskiego, ul.Nowoursynowska 159 C, 02-766 Warszawa

autor

Wielgosz M.

Bibliografia

• 1.Buéno L., Fioramonto J., Hondé C., Fargeas M. J., Primi M. P.: Central and peripheral control of gastrointestinal and colonic motility by endogenous opiates in conscious dogs. Gastroenterology 1985, 88, 549-556.
• 2.Cesselin F.: Opioid and antiopioid peptides. Fund. Clin.Pharmacol. 1995, 9, 409-433.
• 3.Dhawan B. N., Cesselin F., Reghubir R.: Classification of opioid receptors. Pharmacol. Rev. 1996, 48, 567-592.
• 4.Fang L., Knapp R. J., Horvath R., Matsunaga T. O., Haaseth R. C., Hruby V. J., Porreca F., Yamamura C.: Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity, [w:] J. Wingate (red.): CNS Peptidergic Regulation of Gut Motility: Brain Gut Interaction. CRC Press, New York 1991, 231-243.
• 5.Fioramonti J., Fargeas M. J., Buéno L.: Different targets for i.v. vs i.c.v. administered morphine for its effects on colonic motility nin dogs. Eur. J. Pharmacol. 1985, 117, 115-120.
• 6.Galligan J. J., Burks T. F.: Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat. J. Pharm. Exp. Ther. 1983, 226, 356-361.
• 7.Importa G., Broccardo M.: Effect of selective mu 1, mu 2 and delta 2 opioid receptor agonists on gastric functions in the rat. Neuropharmacol. 1994, 33, 977-981.
• 8.Kania B. F., Brikas P., Buéno L., Fioramonti J., Zaremba-Rutkowska M.: The evaluation of the role of CCK in the opioid modulation of the motility of the gastrointestinal tract in sheep. J. Vet. Pharmacol. Therap. 1999, 22, 153-160.
• 9.Kania B. F., Wielgosz M.: Rola ośrodkowego receptora µ-opioidergicznego w aktywności mioelektrycznej żołądka owcy. Medycyna Wet. 2007, 63, 1478-1481.
• 10.Law P. Y., Wong Y. H., Loh H. H.: Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 389-430.
• 11.Nano J. L., Fournel S., Rampal P.: Citation, characterization of delta-opioid receptors and effects of enkephalins on IRD 98 rat epithelial intestinal cell line. Pflugers-Arch. 2000.
• 12.Petrillo P., Angelici O., Bingham S., Ficalora G., Garnier M., Zaratin P. F., Petrone G., Pozzi O., Sbacchi M., Stean T. O., Upton N., Dondio G. M., Scheideler M. A.: Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-dimethyl-1-methoxy-11-(2-methyl propyl)oxycarbonyl5,6,7,8,12,12b-hexahydro(9H)-4,8 methano benzenofuro [3,2-e]pyrrolo[2,3-gliso quinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neurpathic pain responses. J. Pharmacol. Exp. Ther. 2003, 307, 1079-1089.
• 13.Porreca F., Cowan A., Raffa R. B., Tallarida R. J.: Ketazocines and morphine: effects on gastrointestinal traansit after central and peripheral administration. Life Sci. 1983, 32, 1785-1790.
• 14.Porreca F., Heyman J. S., Mosberg H. I., Omnaas J. R., Vaught J. L.: Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in mouse. J. Pharmacol. Exp. Ther. 1987, 241, 393-400.
• 15.Ruckebusch J., Bardon T., Pairet M.: Opioid control of the ruminant stomach motility: Functional importance of µ, ê and ä receptors. Life Sci. 1984, 35, 1731-1738.
• 16.Sorraing J. M., Fioramonti J., Buéno L., Eno J.: Central and peripheral serotonergic control of forestomach motility in sheep. J. Vet. Pharmacol. Therap. 1985, 8, 312-319.
• 17.Thomasy S. M., Moeller B. C., Syanley S. D.: Comparison of opioid receptor binding in horse, guinea pig, and rat cerebral cortex and cerebellum. Vet. Anesth. Analg. 2007, 17, 565-576.
• 18.Tsuchida D., Fukuda H., Koda K., Miyazaki M., Pappas T. N., Takahashi T.: Central effect of mu-opioid agonists on antral motility in conscious rats. Brain Res. 2004, 1024, 244-250.
• 19.Waldhoer M., Bartlett S. E., Whistler J. I.: Opioid receptors. Annu. Rev. Biochem. 2004, 73, 953-990.
• 20.Ward S. J., Takemori A. E.: Relative involvement of receptor subtypes in opioid-induced inhibition of gastrointestinal transit in mice. J. Pharmacol. Exp. Ther. 1983, 224, 359-363.
• 21.Wood M., Daniel A. M., Papini M. R.: Selective effects of the δ-opioid receptor agonist DPDPE on consommatory successive negative contrast. J. Neurophysiol. 2000, 83, 2691-2698.
• 22.Zaremba-Rutkowska M.: Rola antagonistów cholecystokininy w modulacji opioidowej motoryki przewodu pokarmowego owcy. Rozprawa doktorska. Wydz. Med. Wet. SGGW, Warszawa 2000, 20-24, 64-72.